The art of partnerships Program Agenda
|
|
|
- Rolf Long
- 5 years ago
- Views:
Transcription
1 The art of partnerships Program Agenda Developing Countries Vaccine Manufacturers Network 19th Annual General Meeting 29 th October - 1 st November 2018 Kunming, China
2 DAY 1 - Monday, October 29 th - Pre-meetings for DCVMN Members only 08:30-10:00 Registrations - Welcome coffee 8:30-12:30 DCVMN Executive Committee Meeting / Room #1 Private meeting for Executive Committee members: by Invitation Only 10:00-12:30 Satellite Workshop for DCVMN corporate members only: Responsible Innovation and the Future Vaccine Manufacturing Hub - Hosted by The Future Vaccine Hub Chair: R. Shattock (Leader FVMH) Co-chair: tbd 10:00-10:15 Introduction to the Future Vaccine Manufacturing Hub. R. Shattock/K. Kothari 10:15-10:30 Replicon RNA vaccines. R. Shattock 10:30-10:50 Enhanced yeast expression platforms QA & Insect-cell baculovirus expression system (IC- BEVS). X. Xu 10:50-11:10 Insect-cell baculovirus expression system (IC- BEVS). I. Berger 11:10-11:30 Process optimisation, formulation, and heat stabilization. R. Chen 11:30-11:50 QA and QC support. M. Page 11:50-12:10 Vaccine specific modelling and decisional tools. Z. Kis 12:10-12:30 Q&A DCVMN Executive Committee Meeting / Room #1 Private meeting for Executive Committee members: by Invitation Only 14:00-16:00 Satellite Symposium for all participants Responsible Innovation: Cost-effective manufacturing and economies of scale Hosted by Premium Partners Chair: CB. Tan (Merck) Co-chair: T. Prusik (Temptime) 14:00-14:20 Adapting VVM for the Next Generation Supply Chain. T. Prusik (Temptime) 14:20-14:40 R. Patil (Merck) 14:40-15:00 Adenovirus based vaccine manufacturing - technical and economic considerations. M. Lundgren and G.Jagschies (GE) 15:00-15:20 T. Kram (Rommelag) 15:20-15:40 Q&A Time for Networking and private meetings 15:40-16:00 Coffee break 16:00-18:00 DCVMN General Assembly: for DCVMN members only 18:00-19:30 Welcome Reception / For all delegates Time for Networking and private meetings Page 2 of 5
3 DAY 2 Tuesday, October 30 th 08:30-09:00 Registrations 09:00-10:00 Plenary Opening Session / Grand Ballroom 09:00-10:00 Chair: M. Datla, (President, DCVMN) Co-chair: L. Qihan, (CEO & President, IMBCAMS) 15 min each 10:00-10:30 Coffee Break Opening Address M. Datla (President, DCVMN) Welcome Speech by L. Qihan (CEO & President, IMBCAMS) Inaugural Address Ministry of Health and Welfare China/Yunnan Inaugural Speech: WHO new strategic directions M. Simao (Assistant Director General for Access, WHO) 10:30-12:30 Partnerships for Vaccine Forum / Grand Ballroom Chair: Y. Lingjiang (Sinopharm) Cochair: H. Kim (SK) 10:30-11:30 Keynote lectures 20 min each Inaugural Keynote Lecture BMGF strategy moving forward with partnerships A. Oswald (BMGF) PATH 40 years of transformational innovations S. Davis (PATH) E. Kadilli (UNICEF) 11:30-11:50 UNICEF (tbc) 11:50-12:30 Panel discussion I moderated by J. Chu (CHAI) Partnerships across generations: creating a healthy future Panelists: S. Davies (PATH), A. Oswald (BMGF), M. Simao (WHO), M. Zuma (Bio-Manguinhos) 14:00-17:30 Procurement, Financing, and Innovation Fora / Grand Ballroom 14:00-15:00 Panel discussion II moderated by V. Pavliak (IVI) 15:00-16:00 Panel discussion III moderated by GAVI 16:00-16:30 Coffee Break 16:30-17:30 Panel discussion IV moderated by G. Rockman (GHIF) 17:30-18:30 Free Time for Networking Vaccines R&D J. Thommes (BMGRI), R. Shattock (Imperial), DT. Do (Vabiotech), A. Tomar (Cadila) Innovative Procurement and Globalization for vaccines D. Hein (GAVI), J. Fitzsimmons (PAHO), T. Cernuchi (WHO), S. Rautio (UNICEF), DCVM 5, DCVM 6 Funding Landscape: New prospects for investing in Vaccines F. Kristensen (CEPI), M. Datla (BioE), Y. Kim (RIGHT Fund), S. Prasad (Bharat), J. Yip (BMGF), DCVM 9 DCVMN Elections members only event 19:00-21:00 Cultural Dinner / Grand Ballroom sponsored by IMBCAMS for all delegates Page 3 of 5
4 DAY 3 Wednesday, October 31st 09:00-10:30 Regulatory Forum: increasing regulatory convergence / Grand Ballroom A Chair: N. Dellepiane (DCVMN consultant) Co-chair: S. Desai (Zydus Cadila) 09:00-10:30 The collaborative procedure for advancing vaccines registration in emerging countries, E. Cooke (WHO) CFDA representative (tbc) Joint scientific and ethics reviews of clinical trial applications. D. Maiga (AVAREF) Opportunities for improvements in vaccines registration. N. Dellepiane (DCVMN consultant) Future vaccines Forum / Grand Ballroom B (15 minutes each) Chair: S. Jadav (Serum Institute of India) Cochair: H. Kim (LG) Accelerating vaccine discovery and development. J. Thommes (BMGRI) Experience with the first wp based fully liquid hexavalent vaccine. L. Mohanty (Panacea) New 5-valent meningitis vaccine. R. Dhere (Serum Institute of India) PCV-13 clinical results (Walvax) Development of shigella vaccine. L. Du (Zhifei) 10:30-11:00 Coffee Break 11:00-12:30 Future QC assays and standards Forum: QC Tech transfer to DCVMs / Grand Ballroom A Chair: tbd Cochair: tbd WHO Global NCLs Network. U. Rosskopf (WHO) Global efforts to improve vaccine testing. I. Feavers (NIBSC) Availability of high quality, affordable, and accessible monoclonal antibodies to support PCV development, D. Boyle and N.Agarwal (PATH) 14:00-15:30 Updates on progress of global vaccination initiatives / Grand Ballroom Chair: B.Giersing Co-chair: S. Gao (tbc) Future vaccines Forum / Grand Ballroom B (15 minutes each) part 2 Chair: A. Wong (Walvax) Co-chair: J. Kim (tbc) Second generation rotavirus vaccines. D. Steele (BMGF) Rabies monoclonal product. S. Kumar (Zydus Cadila) Novel vaccines against mosquito born viruses. S. Misailidis (Biomanguinhos) Clinical development of sabin IPV. W. Meng (Sinovac) Advancements in novel vaccine manufacturing: HPV & HEV. J. Shih (Innovax) Dengue, second generation vaccines. A. Precioso (Butantan) Updates on progress of UNICEF / Grand Ballroom Chair: S. Rautio (UNICEF) Co-chair: 14:00-15:30 Gavi Market shaping (TBC) BMGF. D. Steele EuBiologics. Y. Baik (MAP) R. Menon SII / V. Paradkar, Biological E (tbc) PATH D. Kristensen (tbc) Country rep : Yot (tbc) S. Rautio (UNICEF) Key indicators for development, production planning and markets. Public health disease prevention and control objectives, priority lists for diseases, UNICEF market notes, Gavi Roadmaps, regulatory requirements for market access Influenza vaccine supply hubs. C. Nannei (WHO) Emergency use of unlicensed vaccines 15:30-16:00 Coffee Break 16:00-17:00 Plenary Closing Session / Grand Ballroom Page 4 of 5
5 16:00-17:00 Chair: M. Datla, (President, (DCVMN) Closing Keynote Lecture Closing Remarks Host of AGM 2019 Day 4 - Thursday, November 1 st Optional site visits to IMBCAMS facilities (tbc) Page 5 of 5
The art of partnerships Program Agenda
The art of partnerships Program Agenda Developing Countries Vaccine Manufacturers Network 19th Annual General Meeting 29 th October - 1 st November 2018 Kunming, China DAY 1 - Monday, October 29 th - Pre-meetings
The art of partnerships Program Agenda
The art of partnerships Program Agenda Developing Countries Vaccine Manufacturers Network 19th Annual General Meeting 29 th October - 1 st November 2018 Kunming, China DAY 1 - Monday, October 29 th - Pre-meetings
PROPOSED AGENDA. PROPOSED AGENDA AGM 24-27th October 2016, Buenos Aires
PROPOSED AGENDA AGM 24-27th October 2016, Buenos Aires Day 0 Monday October 24 th 8:30 18:30 Registration GRAND FOYER 9:00 18:00 Pre-meetings / For DCVMN Members only Quinquela 9:00 10:00 WHO Satellite
UNICEF 2017 VACCINE INDUSTRY CONSULTATION October 2017 UNICEF Supply Division, Oceanvej 10-12, 2150, Nordhavn, Copenhagen, Denmark
UNICEF 2017 VACCINE INDUSTRY CONSULTATION 05-06 October 2017 UNICEF Supply Division, Oceanvej 10-12, 2150, Nordhavn, Copenhagen, Denmark AGENDA INTRODUCTION UNICEF works in 190 countries and territories
Protecting people against known and emerging infectious diseases globally
Protecting people against known and emerging infectious diseases globally 18 October 2017 SAGE Geneva By Mahima Datla President, DCVMN 1 Agenda Introduction to DCVMN DCVMN s contributions Suggested areas
Global vaccine market
Global vaccine market Global Vaccine and Immunization Research Forum Amie Batson Chief Strategy Officer, PATH March 2016 PATH/Eric Becker Agenda Overview of global vaccine market Demand Supply Financing
IVI STRATEGY ARTICULATION. October 12, 2015
IVI STRATEGY ARTICULATION October 12, 2015 Overall messages for today Our Vision and Mission are as relevant today as they have ever been We need to focus on the diseases and activities where we can have
GAVI Role in IPV Introductions
GAVI Role in IPV Introductions Melissa Malhame 12 th WHO/UNICEF Consultation with OPV/IPV Manufacturers and National Regulatory Authorities Geneva, Switzerland, 10 GAVI vaccine support Currently supported
NVI Experience and Concept of Central Technology Hub
NVI Experience and Concept of Central Technology Hub Jan Hendriks Netherlands Vaccine Institute (NVI) MSF/Oxfam Consultation improving access and stimulating vaccine development for use in resource pour
Industry Partner Program
Industry Partner Program ABOUT BCNET BCNET is a not-for-profit organization that represent the interests of our members colleges, universities and research institutes in British Columbia. We continuously
VACCINE MARKETS OVERVIEW SESSION
VACCINE MARKETS OVERVIEW SESSION Robyn Iqbal Program Officer, Vaccine Delivery Market Dynamics UNICEF SD Manufacturers Meeting Copenhagen October 8, 2014 DRAFT Bill & Melinda Gates Foundation DISCUSSION
Partnerships for Vaccines Forum
October 30, 2018 Partnerships for Vaccines Forum PATH s 40+ years of transformative innovation Steve Davis President & CEO, PATH Photos: PATH/Aaron Joel Santos, PATH/Gabe Bienczycki, PATH/Gabe Bienczycki
Annual General Meeting 2017 Speakers Book
1 2 Day 1, 25 th Sept 2017 9:00-12:30 Chair: Ms. Debra Kristensen Director, Vaccine and Pharmaceutical Technologies, PATH PATH /UNICEF/WHO workshop on Innovative Solutions for Vaccine Supply and Distribution
Bureau Advisory Group Meeting 4 March 2019
Bureau Advisory Group Meeting 4 March 2019 Doc No: CFS/BurAG/2019/03/04/02 Planning Notes The Chair has met with the office of the Director-General and communicated the preference of CFS for FAO to host
Outline. Role of Developing Country Vaccine Industry For Meeting Global Vaccine Needs. Immunization Landscape ADVAC 2013
Role of Developing Country Vaccine Industry For Meeting Global Vaccine Needs ADVAC 2013 Dr. Suresh Jadhav Executive Director Serum Institute of Limited Maharashtra,, 411028 ssj@seruminstitute.com France,
Pneumococcal Symposium
3 rd Regional Pneumococcal Symposium 13-14 14 February 2008 Istanbul, Turkey Dr. Akira Homma Bio-Manguinhos, Fiocruz DCVMN Developing Countries Vaccine Manufacturers Network -DCVMN- Formed in 2000, Bandung,
Inaugural Keynote Lecture: Contributions of Gavi and DCVMN to the global vaccine markets
Inaugural Keynote Lecture: Contributions of Gavi and DCVMN to the global vaccine markets Seth Berkley M.D, CEO, Seoul www.gavi.org 1 Gavi s mission, model and achievements to date Gavi s mission Saving
Call for Strategic Partners, Sponsors and Exhibitors
Presents Call for Strategic Partners, Sponsors and Exhibitors Sunday, June 9 Tuesday, June 11, 2013 The Ritz-Carlton Sarasota, Florida www.planetphilanthropy.org Greetings from Planet Philanthropy 2013!
2018 Fall NAMD Meeting Washington Hilton 1919 Connecticut Avenue, NW Washington, DC November 12-14, 2018
Preliminary DRAFT AGENDA 2018 Fall NAMD Meeting Washington Hilton 1919 Connecticut Avenue, NW Washington, DC 20009 November 12-14, 2018 Monday, November 12, 2018 State Only Day 8:00 AM - 5:00 PM Registration
Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing. Washington, DC January 14-16, Agenda.
Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing Washington, DC January 14-16, 2013 Agenda January 14, 2013 7:45 am 5:00 pm Registration And Information 8:45 am 9:00 am Opening
2018 Corporate Partnership Opportunities
2018 Corporate Partnership Opportunities Moving Forward & Looking Back. Middle Tyger Community Center is celebrating 20 years of building healthier rural communities in Spartanburg County. Over the coming
Call for Strategic Partners, Sponsors and Exhibitors
Presents Call for Strategic Partners, Sponsors and Exhibitors Sunday, May 22 Tuesday, May 24, 2016 Caribe Royale All- Suites Hotel and Conference Center Orlando, Florida www.planetphilanthropy.org Greetings
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition
5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition SIXTH DRAFT OF THE PROGRAM AUGUST 28, 2014 Wednesday, October 5, 2016 08:00-16:30 Post Graduate course (To be developed by the
2018 Fall NAMD Meeting Washington Hilton 1919 Connecticut Avenue, NW Washington, DC November 12-14, 2018
Preliminary DRAFT AGENDA 2018 Fall NAMD Meeting Washington Hilton 1919 Connecticut Avenue, NW Washington, DC 20009 November 12-14, 2018 Monday, November 12, 2018 State Only Day 8:00 AM - 5:00 PM Registration
Draft Programme (05 May 2016)
Innovations in sustainable Draft Programme (05 May 2016) Draft 7 th Meeting of the South-East Asia Region Immunization Technical Advisory Group (SEAR ITAG) 6-10 June 2016, New Delhi (India) Day 1, Monday,
EXPERT CONSULTATION ON UNLOCKING GLOBAL COLLABORATION TO ACCELERATE INNOVATION FOR ALZHEIMER S DISEASE AND DEMENTIA.
EXPERT CONSULTATION ON UNLOCKING GLOBAL COLLABORATION TO ACCELERATE INNOVATION FOR ALZHEIMER S DISEASE AND DEMENTIA 20-21 June, 2013 The Harris Manchester College Oxford, United Kingdom Background The
How and Why Vaccines Are Developed by Industry. Stanley A. Plotkin
How and Why Vaccines Are Developed by Industry Stanley A. Plotkin Merieux 2012 1 Why Vaccines are Different than Drugs 1) Given to healthy people, high safety required 2) Larger governmental role 3) Low
Perspectives on Ensuring Access to Vaccines in Lower Income Countries
Perspectives on Ensuring Access to Vaccines in Lower Income Countries Greg Widmyer Deputy Director, Vaccine Delivery Foundation Merieux January 20, 2015 Bill & Melinda Gates Foundation BMGF GLOBAL PROGRAMS
Gavi s private sector engagement approach
Gavi s 2016-2020 private sector engagement approach SCALING INNOVATION FOR IMPACT Gavi Board technical briefing session 21 June 2016 Geneva, Switzerland Reaching further, together www.gavi.org A HISTORY
WEEK OF MARCH 12, 2018 VANCOUVER, BC
WEEK OF MARCH 12, 2018 S P O N S O R S H I P O P P O R T U N I T I E S Inspiring talent, imaginative ideas, and innovative actions. Creating a community of leaders - now! What is Leading Change? Leading
GAVI, THE VACCINE ALLIANCE
#vaccineswork GAVI, THE VACCINE ALLIANCE Partnerships for Health Outcomes Susan Brown July, 2017, New York Gavi/2012/Doune Porter www.gavi.org 1 ABOUT GAVI Gavi s mission: to save children s lives and
AGENDA THE ASEAN-TRIPARTITE RABIES MEETING 4-6 DECEMBER 2018 HA NOI, VIET NAM
DAY ONE - Ha Noi, Tuesday 4 December 2018 AGENDA THE ASEAN-TRIPARTITE RABIES MEETING 4-6 DECEMBER 2018 HA NOI, VIET NAM 08:00 08:30 Registration Organisers 08:30 09:00 Opening Session Co-Chaired by: Dr
Development of Vaccine Security at the Regional Level
Workshop among ASEAN countries on Opportunities for Regional Vaccine Security September 30 to October 3, 2014, Cape Panwa, Phuket, Thailand Development of Vaccine Security at the Regional Level Stephane
Rotavirus Vaccine. Supply and Procurement Roadmap. The Market Shaping Goal. Public Summary. Rotavirus Supply and Procurement Roadmap UPDATE 2016
The Market Shaping Goal Shape markets for vaccines and other immunisation products to achieve moderate or high levels of healthy markets dynamics. Supply and Procurement Roadmap Rotavirus Vaccine Public
41 st Annual Conference UN MUNDO, MUCHAS VOCES (ONE WORLD, MANY VOICES) November 1-4, 2018 Puebla, Mexico. A Guide for Partners
41 st Annual Conference UN MUNDO, MUCHAS VOCES (ONE WORLD, MANY VOICES) November 1-4, 2018 Puebla, Mexico A Guide for Partners The Fulbright Association is the official U.S. alumni organization of the
Michel BAIJOT Vice President, WW Business Development & Strategic Alliances
Technology Transfer and Vaccines: The GSK Experience WHO Workshop on Technology Transfer for Local Manufacturing Capacity of Vaccines Geneva, November 30th, 2010 Michel BAIJOT Vice President, WW Business
SOIL HEALTH HUMAN HEALTH CONFERENCE
SPONSOR BRIEF CONFERENCE on CONNECTIONS BETWEEN SOIL HEALTH and HUMAN HEALTH Tuesday, October 16 th Wednesday, October 17 th, 2018 Doubletree by Hilton, Silver Spring, MD Planned for 150 Attendees (Half
COMMUNICATION ON ENGAGEMENT Reporting on MI s engagement with the private sector
UN GLOBAL COMPACT COMMUNICATION ON ENGAGEMENT Reporting on MI s engagement with the private sector Period covered by the Report: January 2014 to December 2015 www.micronutrient.org 29 January 2016 To our
Readiness for Microbial Threats 2030: Exploring Lessons Learned since the 1918 Influenza Pandemic A Workshop
Readiness for Microbial Threats 2030: Exploring Lessons Learned since the 1918 Influenza Pandemic A Workshop Objectives: Agenda NOVEMBER 27-28, 2018 The National Academies Keck Building 500 Fifth Street
Global update on temperature monitoring
Global update on temperature monitoring Why bother about temperature monitoring Objectives of the immunization supply chain Impacts of temperature excursions If undetected If detected Availability of vaccines
DIOXIN SYMPOSIUM MEETING PLANNING
DIOXIN SYMPOSIUM MEETING PLANNING History & General Information A listing of future and past Dioxin Symposia can be found on the Symposium page. The International Dioxin Symposium has been held annually
What is to be done to respond to country needs and comply with WHA and SAGE recommendations?
New vaccine introduction in MIC: current initiatives to address financial challenges What is to be done to respond to country needs and comply with WHA and SAGE recommendations? 1 Plan SAGE recommendations
TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE
TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE Aurélia Nguyen Tuesday 20 January 2015, Veyrier-du-Lac, France www.gavi.org AGENDA Market
Call for Strategic Partners, Sponsors and Exhibitors
Presents Call for Strategic Partners, Sponsors and Exhibitors Sunday, June 25 Tuesday, June 27, 2017 Hilton Downtown Tampa, Florida www.planetphilanthropy.org Greetings from Planet Philanthropy 2017! The
Gavi s Sustainability and Transition Approach
Gavi s Sustainability and Transition Approach Santiago Cornejo Director, Immunisation Financing and Sustainability 13 June 2018 www.gavi.org Countries tend to face various programmatic and financing challenges
Global Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
Regulatory harmonization and alliances to foster vaccination
Regulatory harmonization and alliances to foster vaccination Developing Country Vaccine Manufacturers Network 14th AGM 7-9 October 2013, Hanoi Drs David Wood and Ivana Knezevic WHO/HIS/EMP/TSN Outline
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES
WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES Immunization and vaccine development in the last decade Since the Millennium Summit in 2000, immunization substantial international
Technology Transfer from the Perspective of IFPMA vaccine members
Technology Transfer from the Perspective of IFPMA vaccine members WHO Workshop on Technology Transfer for Local Manufacturing Capacity of Vaccines Michael Watson (Sanofi Pasteur) Chair of IFPMA Biologicals
SPONSORSHIP OPPORTUNITIES
2014-2015 SPONSORSHIP OPPORTUNITIES The vision of the Saskatchewan Construction Association (SCA) is to provide collaborative and trusted leadership that sustains a prosperous construction industry and
Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security
Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security May 17-19 2017, Wuhan, China Meeting Program Note: Each report will take 25 minutes including
RIGHT (Research Investment for Global Health Technology, Korean GHIT) November 2017
RIGHT (Research Investment for Global Health Technology, Korean GHIT) November 2017 ROK intends to create a new public-private partnership modeled after successful Japanese GHIT fund Research Investment
HOMELESSNESS IN CANADA
HOMELESSNESS IN CANADA At least 235,000 Canadians access homeless emergency services or sleep outside in a given year, with over 35,000 Canadians homeless on any given night. Bucking this trend are communities
WHO Update Tania Cernuschi & Patrick Lydon
IVB/EPI/STF WHO Update Tania Cernuschi & Patrick Lydon Session 2 UNICEF Vaccine Industry Consultation 5-6 October 2017 IVB/EPI/STF 1 The Big Picture WHO s Immunization Department Supply, Technologies and
Last mile vaccine distribution to rural health centres. Faheem Merchant
Last mile vaccine distribution to rural health centres Faheem Merchant New Global Immunization Goals 2000 - Millennium Development Goal # 4 Reduce under 5 child mortality by 2/3 between 1990 and 2015.
MARKET UPDATE: ROUTINE VACCINE INTRODUCTIONS PCV HPV ROTA
UNICEF/UN074388/LeMoyne MARKET UPDATE: ROUTINE VACCINE INTRODUCTIONS PCV HPV ROTA Vaccine Industry Consultation October 2018 Pneumococcal Conjugate Vaccine (PCV) Background The AMC initiative has opened
Neurology & Brain Disorders
International Congress on Neurology & Brain Disorders 16-18 September, 2019 London, UK "Accelerate the latest innovations and developing trends on Neurology and Brain Disorders" About Conference Science
SPONSOR AND EXHIBITOR OPPORTUNITIES Your Invitation
SPONSOR AND EXHIBITOR OPPORTUNITIES Your Invitation Exhibit and sponsorship opportunities now available for Northwest Rural Health Conference March 26-28, 2018 at the Davenport Grand Hotel in Spokane,
Vaccine Development in the Developing World; past, present and future: SEAR Perspective
Speech by Dr Samlee Plianbangchang Regional Director, WHO South-East Asia Vaccine Development in the Developing World; past, present and future: SEAR Perspective 15 June 2010 Bangkok, Thailand Vaccine
PCHAlliance Spring Summit May 2018, Sitges, Spain Agenda at a glance
PCHAlliance Spring Summit 2018 29-31 May 2018, Sitges, Spain Agenda at a glance All Summit activities take place at Hotel Calipolis with the exception of the 31 May TicSalut Live Demo Tuesday, 29 May 2018
Sponsorship Opportunities
Sponsorship Opportunities Contents Page Introduction 3 About One Nucleus 3 Why Sponsor One Nucleus? 4 Sponsorship Benefits 4 Corporate Sponsorship 5 Event Sponsorship 6 - Network Meetings and BioWednesdays
RECYCLE Annual Conference & Exhibition. June 12 14, 2016 I Cycle, You Cycle, We Cycle. Sunday, June 12, 2016 Preliminary Events
2016 Annual Conference & Exhibition Renaissance World Golf Village- St. Augustine, FL June 12 14, 2016 I Cycle, You Cycle, We Cycle RECYCLE Sunday, June 12, 2016 Preliminary Events Noon 6:00 pm Registration
2014 KASBP Fall Symposium
2014 KASBP Fall Symposium Hosted by KASBP, Daewoong and Green Cross Preliminary Program Nov. 7 (Friday) Nov. 8 (Saturday), 2014 THE WESTIN GOVERNOR MORRIS 2 Whippany Road Morristown, New Jersey 07960 Korean
Third meeting of the Technical Cooperation Group on SDG4- Education 2030 Indicators (TCG) Agenda
Third meeting of the Technical Cooperation Group on SDG4- Education 2030 Indicators (TCG) Agenda Venue: UNESCO Institute for Statistics 5255 Avenue Decelles Montreal, Canada 2 TCG3 - Agenda Wednesday,
Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 1 3 April 2014 CCV/CICG, Geneva
Version: 14 March 2014 Agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 1 3 April 2014 CCV/CICG, Geneva Tuesday, 1 April 2014 Time Session Purpose of session, target outcomes
SUSTAINABLE OCEAN SUMMIT 2016
SOS 2016 SPONSORSHIP INFORMATION DOCUMENT SUSTAINABLE OCEAN SUMMIT 2016 The International Ocean Business Forum to Advance Responsible Use of the Seas Rotterdam / 30 November 2 December 2016 1 Sustainable
Draft agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 5-7 April 2011 CCV/CICG, Geneva
Version: 10 February 2011 Draft agenda Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 5-7 April 2011 CCV/CICG, Geneva Tuesday, 5 April 2011 Time Session Purpose of session, target
Inaugural Meeting of the Global HIV Prevention Coalition October 2017
Inaugural Meeting of the Global HIV Prevention Coalition 10-11 October 2017 Grand Hotel Kempinski Geneva Provisional Agenda (Day 1) 10 October Time Session Speaker/Facilitator 08:30 Registration, Coffee
Vaccines Supply Shortages Challenges & Opportunities
The Pan American Health Organization (PAHO) Revolving Fund for Vaccine Procurement Vaccines Supply Shortages Challenges & Opportunities Developing Country Vaccine Manufacturers Network (DCVMN) www.paho.org/immunization
V3P: Region Fact Sheet
V3P: Region Fact Sheet Highlights The 1 region market is 15% of the global market in volume and 63% in value. The regional vaccine procurement habits are different from the rest of the world in several
GOTHENBURG April Sponsorship & Exhibition Opportunities
GOTHENBURG 12-15 April 2016 Sponsorship & Exhibition Opportunities Proposed Speakers Maureen Bisognano President and Chief Executive Officer of the Institute for Healthcare Improvement (IHI), USA Hallå
The G8 Dementia Summit: A Giant Step Forward for Dementia
The G8 Dementia Summit: A Giant Step Forward for Dementia January 28, 2014 Mimi Lowi-Young, M.H.A, Dip Bus. Admin., FACHE, FCCHL Chief Executive Officer, Alzheimer Society of Canada Overview 1. Background
March 9 and 10, 2017 Bethesda North Marriott (DC Metro area)
March 9 and 10, 2017 Bethesda North Marriott (DC Metro area) Genetic Alliance is celebrating its 30 th anniversary this year. Consistent with our desire to always focus on what matters, this meeting will
V3P: Region Fact Sheet
V3P: Region Fact Sheet Highlights The 1 region market is 4% of the global market in volume and 5% in value. The regional vaccine procurement habits are different from the rest of the world in several ways,
Improving the vaccine supply chain in developing countries via increasing freeze protected cold chain equipment. October, 2014
Improving the vaccine supply chain in developing countries via increasing freeze protected cold chain equipment October, 2014 CHAI s mission is to save lives by increasing access to health commodities
Global Partnership for Zero Leprosy Leadership Team Inaugural Meeting
Global Partnership for Zero Leprosy Leadership Team Inaugural Meeting 20-22 March 2018 Lepra, Colchester, UK Meeting Participants Leadership team members Arielle Cavaliero, Leprosy Project Manager, Novartis
SPONSORSHIP PROSPECTUS
SPONSORSHIP PROSPECTUS International Conference on Advanced Dentistry and Oral Health November 28-30, 2018 Dubai, UAE Supporters & Collaborators Venue Crowne Plaza Dubai JOIN OUR COMMUNITY info@globaldentalconferences.org
Gavi Secretariat Update: Progress, priorities and strategies
Gavi Secretariat Update: Progress, priorities and strategies Melissa Malhame UNICEF Vaccine Manufacturer Consultation Copenhagen 8-9 October 2014 www.gavi.org Gavi s impact 2000-2013 2 New vaccines now
The Collegiate Event and Facility Management Association (CEFMA) is dedicated to providing educational programs,
The Collegiate Event and Facility Management Association (CEFMA) is dedicated to providing educational programs, professional development, networking opportunities and best practices to enhance event and
Information for Access
Information for Access WHO Efforts to Enhance Access to Vaccine Supply UNICEF Vaccine Industry Consultation Copenhagen, October 2017 Tania Cernuschi, Vaccine Supply Supply, Technologies, and Financing
Annual Conference. Framing the Future of NGO Excellence SPONSORSHIP OPPORTUNITIES WALTER E. WA SHINGTON CONVENTION CENTER JULY , 2017
Annual Conference SPONSORSHIP OPPORTUNITIES Framing the Future of NGO Excellence JULY 19-2 1, 2017 WALTER E. WA SHINGTON CONVENTION CENTER WA SHINGTON, DC INTRODUCTION AN INVITATION TO SPONSORSHIP In 2017,
2017 MEMBERSHIP PACKET
2017 MEMBERSHIP PACKET GRHCC.ORG Dear new member of the GRHCC, Thank you for your support to the Greater Riverside Hispanic Chamber of Commerce and our members, below are different sponsorship levels
Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,
Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October 5-7 2015 Bangkok, Thailand UNICEF has a key role in vaccine procurement and
Polio post-certification strategy
1 Polio post-certification strategy SAGE Meeting, Geneva, 17 April 2018 Michel Zaffran, Director, Polio Eradication, WHO On Behalf o the GPEI Polio Eradication and Endgame Strategy 1. Poliovirus detection
Responsible Business Week 2018: April, 2018 Sponsorship Pack
23-27 April, 2018 Sponsorship Pack www.bitc.org.uk/rbweek Sponsorship Proposal Every Business Can Make a Difference, Place by Place Responsible Business Week (23-27 April 2018) is an annual awareness campaign
Diagnostics product development projects
Page 0 Diagnostics product development projects Smiljka de Lussigny Technical Officer, HIV UNITAID Copenhagen, 23 September 2013 Page 1 1 2 3 About UNITAID HIV diagnostics market UNITAID s current investment
FINAL PROGRAM IGNITING CHANGE & INNOVATION: THE IMPACT OF HEALTH EDUCATION 1
FINAL PROGRAM IGNITING CHANGE & INNOVATION: THE IMPACT OF HEALTH EDUCATION 1 SCHEDULE AT-A-GLANCE START END EVENT ROOM TUESDAY, APRIL 3 12:00PM 7:00PM REGISTRATION OPEN The Landing 9:00AM 5:00PM CASE STUDY
SINGAPORE. 12 th PVRI Annual World Congress. on Pulmonary Vascular Disease WELCOME TO. Date // January 2018
Date // 21-25 January 2018 12 th PVRI Annual World Congress on Disease Hotel // Mandarin Orchard Hotel. Singapore WELCOME TO SINGAPORE Pre-Congress MEETINGS Sunday 21 January 2018 PVRI Board of Directors
NACCU 2019 Annual Conference April 7-10, 2019 Connecticut Convention Center, Hartford, CT
NACCU 2019 Annual Conference April 7-10, 2019 Connecticut Convention Center, Hartford, CT Build Brand Awareness as a NACCU 2019 Sponsor Sponsorship provides you with multiple opportunities to put your
China Human Vaccine Industry Report, Jun. 2016
China Human Vaccine Industry Report, 2016-2020 Jun. 2016 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
GAVI S VACCINE INVESTMENT STRATEGY
GAVI S VACCINE INVESTMENT STRATEGY Judith Kallenberg, Head of Policy PDVAC 22 June 2017, Geneva Reach every child www.gavi.org Gavi finances vaccines and immunisation through three routes ($9 Billion in
SPONSORSHIP INFORMATION DOCUMENT. Izzy Dempsey Nov 2018 Hong Kong. 29 Nov - 1 Dec 2017 Halifax, Canada
SPONSORSHIP INFORMATION DOCUMENT 2018 Izzy Dempsey 14-16 Nov 2018 Hong Kong 29 Nov - 1 Dec 2017 Halifax, Canada WOC SUSTAINABLE OCEAN SUMMIT The challenge The ocean is an interconnected global ecosystem
Women s Cancer Initiative: A joint commitment to save lives AGENDA
8:30 9:00am Women s Cancer Initiative: A joint commitment to save lives REGISTRATION 9:00 9:30am WELCOME AND INTRODUCTIONS First Meeting of the PAFNCDs Women s Cancer Initiative Pan American Health Organization,
SPONSORSHIP OPPORTUNITIES AND BENEFITS AFOA Canada invites your organization to take advantage of an incredible sponsorship opportunity.
SPONSORSHIP AND BENEFITS AFOA Canada invites your organization to take advantage of an incredible sponsorship opportunity. This national conference gives you the opportunity to promote your services, products
GAVI Alliance. Aurelia Nguyen, Director Policy & Market Shaping. IPC Meeting 30 May 2013
GAVI Alliance Aurelia Nguyen, Director Policy & Market Shaping IPC Meeting 30 May 2013 GAVI Update GAVI Alliance Overview 4 Strategic Goals 3 Market Shaping Objectives GAVI Supported Vaccines Critical
Programme. "Quality Control Laboratories: How to Inspect" PIC/S Pre- Seminar and Seminar
PIC/S Pre- Seminar and Seminar "Quality Control Laboratories: How to Inspect" Programme Hosted by Taiwan Food and Drug Administration, Ministry of Health and Welfare 11-15 September 2017 Grand Victoria
From development to delivery: Decision-making for the introduction of a new vaccine
From development to delivery: Decision-making for the introduction of a new vaccine Prince Mahidol Award Conference Bangkok, Thailand 1-2 February 2007 Dr. J.M. Okwo-Bele Department of Immunization, Vaccines
Sponsorship & Hosting Opportunities. Connect with our family enterprise community Canada s largest and most influential industry segment
2016 2017 Sponsorship & Hosting Opportunities Connect with our family enterprise community Canada s largest and most influential industry segment Join the Conversation Connect with Family Business REACH
JOIN US TO INTEGRATE CLINICAL RESEARCH AND HEALTH CARE
JOIN US TO INTEGRATE CLINICAL RESEARCH AND HEALTH CARE #BridgeTheGap April 4-5, 2018 National Harbor, MD bridgingclinical.com LET'S BUILD A BRIDGE Work with us to bridge the gap between clinical research
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing